Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Arcellx Inc (ACLX)

Arcellx Inc (ACLX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 886,897
  • Shares Outstanding, K 43,819
  • Annual Sales, $ 0 K
  • Annual Income, $ -64,970 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.65
Trade ACLX with:

Options Overview Details

View History
  • Implied Volatility 121.97% ( +12.39%)
  • Historical Volatility 63.64%
  • IV Percentile 82%
  • IV Rank 76.60%
  • IV High 133.44% on 10/14/22
  • IV Low 84.43% on 08/11/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 87
  • Volume Avg (30-Day) 130
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 2,312
  • Open Int (30-Day) 1,921

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.85
  • Number of Estimates 3
  • High Estimate -0.76
  • Low Estimate -0.99
  • Prior Year -39.85
  • Growth Rate Est. (year over year) +97.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.71 +3.74%
on 12/02/22
23.39 -17.02%
on 11/07/22
-2.82 (-12.69%)
since 11/04/22
3-Month
16.73 +16.05%
on 09/23/22
24.16 -19.66%
on 11/03/22
+1.24 (+6.82%)
since 09/02/22

Most Recent Stories

More News
Arcellx Reports Third Quarter 2022 Financial Results and Business Progress

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 19.45 (-3.90%)
Wall Street Analysts Think Arcellx, Inc. (ACLX) Could Surge 62%: Read This Before Placing a Bet

The mean of analysts' price targets for Arcellx, Inc. (ACLX) points to a 61.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

ACLX : 19.45 (-3.90%)
Arcellx Announces Participation at the Morgan Stanley 20th Annual Global Healthcare Conference

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 19.45 (-3.90%)
Arcellx Provides Business Highlights and Reports Second Quarter 2022 Financial Results

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 19.45 (-3.90%)
Arcellx Announces Appointment of Maryam Abdul-Kareem as General Counsel

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 19.45 (-3.90%)
Arcellx Announces Closing of Upsized Public Offering of Common Stock and Underwriters' Full Exercise of Option to Purchase Additional Shares

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 19.45 (-3.90%)
Arcellx Announces Upsizing and Pricing of Follow-On Public Offering

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 19.45 (-3.90%)
ASCO 2022: Surprising News in Cancer Research

The American Society of Clinical Oncology (ASCO) just finished up its annual meeting. We have some winners coming out of the conference.

ADPT : 8.24 (-8.04%)
LGND : 69.82 (-3.91%)
ACLX : 19.45 (-3.90%)
Arcellx Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

GAITHERSBURG, Md., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the...

ACLX : 19.45 (-3.90%)
Arcellx Announces Pricing of Initial Public Offering

GAITHERSBURG, Md., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the...

ACLX : 19.45 (-3.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

See More

Key Turning Points

3rd Resistance Point 22.51
2nd Resistance Point 21.45
1st Resistance Point 20.84
Last Price 19.45
1st Support Level 19.17
2nd Support Level 18.11
3rd Support Level 17.50

See More

52-Week High 26.91
Last Price 19.45
Fibonacci 61.8% 18.94
Fibonacci 50% 16.47
Fibonacci 38.2% 14.01
52-Week Low 6.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar